Home

Red Blood Cell Lab
Meet our Staff
News
Licensing
FAQ

Laboratory Services
Routine Hemoglobinopathy
Molecular Assays
Special Hemoglobin Tests
Red Cell Function Tests
Blood Analysis

Advia 120 analysis
Amino Acid composition
NO metabolism
Hemostasis
Cytokines & Growth factors
Adhesion
Inflammation

Data Evaluation

Resource
Study Facilitation
Database Development
Storage
Assay Development

Hemoglobinopathies
Sickle Cell Disease
Thalassemia
Other Hemoglobinopathies

Red Cells
Red Cell Membranes
Red Cell Lipids
Red Cell Metabolism

Financial Policies
Contact us

ICam1

Soluble Human Intercellular Adhesion Molecule-1 (sICAM-1) ELISA

Intercellular Adhesion Molecule-1 (ICAM-1) is a member of the immunoglobulin superfamily and functions as a ligand for the Lymphocyte Function-Associated Antigen-1, which mediates lymphocyte adhesion.  ICAM-1 can be expressed on non-hematopoietic cells of many lineages such as vascular endothelial cells, thymic epithelial cells, other epithelial cells and fibroblasts and on hematopoietic cells such as macrophages, B and T-lymphocytes, and dendritic cells. ICAM-1 is inducible on fibroblasts and endothelial cells by inflammatory mediators such as IL-1, TNF and IFN-g within a few hours and is correlated to the infiltration of lymphocytes into inflammatory lesions. ICAM-1 seems to be the initial marker of inflammatory reactions. The role of ICAM-1 as a disease marker has been demonstrated for a number of different indications and pathological situations.

The sICAM-1 assay is an enzyme-linked immunosorbent assay for the quantitative detection of soluble ICAM-1 in cell culture supernatants, human serum, plasma, urine, amniotic fluid, bile, or other body fluids. The standard curve spans the range of 0.2-10.0 ng/ml and the minimum detectable level is 0.06 ng/ml. Specimens are diluted appropriately to fall within this range. The range of ICAM-1 concentration in normal healthy human serum is 130-300 ng/ml with a mean level of 230.3 ± 47.4 ng/ml. Significantly higher sICAM-1 levels are found in some cancers, HIV, hepatitis B, graft rejection, transplant rejection, arthritis, psoriasis, and diabetes. A decrease in sICAM-1 level can be used to monitor myocardial infarction, ischemia, and reperfusion. This ELISA is for research use only, and is not to be used in diagnostic or therapeutic procedures.

Click here for sample collection and shipping.